<DOC>
	<DOCNO>NCT00389740</DOCNO>
	<brief_summary>The purpose study compare well alendronate raloxifene increase bone density woman osteoporosis experience menopause .</brief_summary>
	<brief_title>A Comparison Study With Alendronate Raloxifene Postmenopausal Women With Osteoporosis ( 0217-189 )</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<mesh_term>Raloxifene Hydrochloride</mesh_term>
	<criteria>Patient postmenopausal ( surgically menopausal ) least 6 month Patient must diagnose osteoporosis Patient spinal anatomy suitable DEXA lumbar spine Patient receive receive treatment prior randomization might influence bone turnover Patient history evidence metabolic bone disease ( postmenopausal bone loss ) Patient receive expect receive course study medication ( study medication ) might alter bone calcium metabolism</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>